COMMUNIQUÉS West-GlobeNewswire

Altimmune Announces Positive Initial Data from Its HepTcell Phase 1 Study

21/12/2017 - 14:00

HepTcell well tolerated in all cohorts Initial data on secondary endpoint demonstrates T cell responses GAITHERSBURG, Md., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage [...]

AMAG Pharmaceuticals Awards $300,000 in Grants to Further Research in Preterm Birth and Neonatal Health

21/12/2017 - 14:00

WALTHAM, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- As part of the company’s ongoing support of maternal and neonatal health, AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced it has awarded four grants totaling [...]

Minerva Neurosciences Announces Enrollment of First Patient in Phase 2b Trial Comparing Seltorexant (MIN-202) Versus Quetiapine as Adjunctive Therapy to Antidepressants in Patients With Major Depressive Disorder

21/12/2017 - 14:00

WALTHAM, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

PolarityTE to Participate in Corporate Access Event in San Francisco, January 8 – 9, 2018

21/12/2017 - 14:00

SALT LAKE CITY, Dec. 21, 2017 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ: COOL ) today announced that its senior management team will host institutional investor and partnering meetings at the LifeSci Advisors [...]

Amicus Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference

21/12/2017 - 13:30

CRANBURY, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced that John F. Crowley, Chairman and Chief Executive Officer, will present a corporate overview at the 36 th Annual J.P [...]

Uptick Newswire “Stock Day” Interviews CEO of Pro-Dex on its 2017 Accomplishments in the Medical Industry

21/12/2017 - 13:30

PHOENIX, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire is the sole producer of the Uptick Network “Stock Day” Podcast and after airing back in January 2016 CEO and host Everett Jolly has interviewed hundreds of CEO’ [...]

Innovation Pharmaceuticals Completes Final Patient Visit in Phase 2b Study of Oral Prurisol for Psoriasis

21/12/2017 - 13:30

BEVERLY, Mass., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc., (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces all patient follow-up visits have been [...]

REPEAT - Cannabis Wheaton Income Corp. Announces New Joint Venture for Development of World's Largest Indoor Cannabis Facility with Licensed Producer Partner FV Pharma Inc.

21/12/2017 - 13:30

VANCOUVER, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or "Wheaton" or the " Company ") is pleased to announce that it has [...]

GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors

21/12/2017 - 13:00

LONDON, Dec. 21, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]

Motif Bio REVIVE-1 Phase 3 Study Results with Iclaprim Published in Peer-reviewed Journal, Clinical Infectious Diseases

21/12/2017 - 13:00

Iclaprim met the primary endpoint Iclaprim was well tolerated in the study Additional data from the previously announced topline results are included in the publication NEW YORK, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Motif [...]

TRACON Pharmaceuticals and Ambrx Announce Development and Commercialization Agreement for TRC105 in China

21/12/2017 - 12:55

Initial Focus in China on Angiosarcoma and Hepatocellular Carcinoma Total Value of Deal up to $143.5 Million for TRACON, Including a $3 Million Upfront Payment and Potential Milestones, Plus Potential Tiered Royalties [...]

Zomedica Pharmaceuticals Corp. Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform

21/12/2017 - 12:55

ANN ARBOR, Mich., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V: ZOM ) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company, today announced it has [...]

DAXOR CORPORATION ANNOUNCES 2017 DIVIDEND

21/12/2017 - 12:00

New York, NY, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, announced the payment of a dividend for 2017. The Board [...]

Histogenics Corporation and MEDINET Co., Ltd Enter Into Licensing Agreement for Development and Commercialization of NeoCart for the Japanese Market

21/12/2017 - 12:00

– Transaction Terms Include a $10 Million Up-front Payment with a Potential of $87 Million in Total Milestones, and Tiered Royalties on Sales ‒ ‒ Japanese Cartilage Repair Market is Large and Growing with Established [...]

Gemphire Therapeutics Announces Initiation of its First NASH Proof-of-Concept Clinical Trial and its Differentiated NASH Program

21/12/2017 - 12:00

Phase 2a trial will investigate gemcabene in Familial Partial Lipodystrophy (FPL) – a rare genetic disease with characteristic presentation of cardiovascular disease and NASH Gemcabene has a differentiated profile based [...]

Mesoblast Receives FDA Regenerative Medicine Advanced Therapy Designation for Its Cell Therapy in Heart Failure Patients With Left Ventricular Assist Devices

21/12/2017 - 12:00

NEW YORK and MELBOURNE, Australia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO ) (ASX:MSB) today announced that the United States Food and Drug Administration (FDA) has granted Regenerative [...]

Evergreen Receives Health Canada “Confirmation of Readiness to Inspect Letter” and Plans to Begin Construction of a Second Site and Building "A" of a Three Million sq ft Expansion Plan

21/12/2017 - 11:14

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VICTORIA, British Columbia, Dec. 21, 2017 (GLOBE NEWSWIRE) -- EVERGREEN MEDICINAL SUPPLY INC. (“EVERGREEN” OR THE “COMPANY”) [...]

Zealand Pharma: Invitation to Capital Market Day in New York on 25 January, and event in Copenhagen on 29 January 2018

21/12/2017 - 10:12

Press release - No. 13/2017 Zealand Pharma: Invitation to Capital Market Day in New York on 25 January, and event in Copenhagen on 29 January 2018 Zealand's management will provide an update on strategy and business [...]

Latvijas Juras medicinas centrs JSC: Data of publication of financial reports in the year 2018.

21/12/2017 - 08:47

Latvia, 2017-12-21 08:47 CET (GLOBE NEWSWIRE) -- Latvijas Juras medicinas centrs JSC: Data of publication of financial reports in the year 2018: Consolidated not audited interim report for the 12 months of 2017 - 19.02. [...]